HiRO Acquires DeltaMed Solutions, Continues to Expand U.S. Footprint
Harvest Integrated Research Organization (HiRO), has announced the successful acquisition of DeltaMed Solutions, headquartered in Somerset, New Jersey. The acquisition, advised by Evercore as financial advisor, marks HiRO’s third CRO acquisition since its establishment in 2020. DeltaMed Solutions is a global life sciences contract research organization (CRO) with a global footprint in the United States and China. DeltaMed Solutions, headquartered in New Jersey, boasts a team of industry professionals with 15-30 years of expertise in serving large to mid-sized pharmaceutical and biotechs. HiRO is a globally oriented CRO with its headquarters in Shanghai, China. With global operations... Read More »
TPG Invests in K2 Medical Research
On June 17 TPG announced that it was making a significant growth investment in K2 Medical Research. K2 Medical Research is a leading clinical research organization (CRO) dedicated to advancing medical science through the efficient and ethical conduct of clinical trials. Its integrated clinical trial site platform specializes in central nervous system trials for leading pharma and biotech sponsor and is focused around complex therapeutic areas including Alzheimer’s, psychiatry and liver disease. The company is based in Florida and operates seven locations across the state. TPG is a global alternative asset management firm with $137 billion of assets under management and... Read More »
Formosa Laboratories Expands North American CRO/CDMO Footprint
Formosa Laboratories, Inc. announced that it has successfully completed its acquisition of SynChem, Inc., headquartered in the Chicago MSA suburb of Elk Grove Village. Founded in 1997, SynChem is a chemistry-based contract research organization (CRO) specializing in organic synthesis, process development and medicinal chemistry. Since its inception, SynChem has completed more than 4,500 projects for wide range of customers, including multi-national pharmaceutical companies, biotech companies, drug discovery companies and chemical and agrochemical companies. Founded in 1995, Formosa Laboratoriesap is a leading active pharmaceutical ingredients (API) supplier and contract development and... Read More »
Fortrea Divests Assets to Arsenal Capital Partners for $345 Million
Fortrea, a Durham, North Carolina-based global contract research organization (CRO), is divesting certain assets to Arsenal Capital Partners for $345 million. The assets being divested relate to Fortrea’s Enabling Services segment, including the businesses Endpoint Clinical and Fortrea Patient Access. In 2023, Fortrea generated revenues of about $3.11 billion compared to about $3.1 billion the previous year, according to the original press release. Arsenal is a New York, New York-based private equity firm that specializes in investments in healthcare and industrial growth companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of more... Read More »
Veranex Acquires Atlanta-Based CRO T3 Labs
Veranex announced that it has acquired T3 Labs for an undisclosed price. T3 Labs is a contract research organization (CRO) in Atlanta offering preclinical testing services. The company brings devices, drugs and biologics from concept to commercialization. Founded in 2021, Veranex is a comprehensive, global, tech-enabled service provider dedicated to the MedTech industry. Offering expert guidance from concept to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation and accelerated market viability assessment. Veranex is backed by Summit Partners, Accelmed and Lauxera Capital... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
